| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	
																	
																	Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer...
																	
																	
																	
																	
																	
																	Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand acce...